Clinical Cell and Vaccine Production Facility

Director: Donald L. Siegel, PhD, MD

The Clinical Cell and Vaccine Production Facility (CVPF) renders bench-to-bedside translational medicine a reality. Equipped with state of the art facilities, the CVPF manufactures cell and gene biotherapeutics and is accredited by the Foundation for the Accreditation of Cellular Therapy (FACT). Further, the CVPF functions as an NCI approved Abramson Cancer Center (ACC) Shared Resource. As an ACC Shared Resource and Path and BioResources core facility, the CVPF supports numerous investigational new drug (IND) protocols. Current protocols target a variety of disease indications (primarily HIV, adult and pediatric cancers, and stroke); many more trials are in development and, once approved, will further expand the scope of diseases targeted for cell and gene therapy.

Contact: Donald L. Siegel, PhD, MD
siegeld@pennmedicine.upenn.edu

For more information, please visit the Facility’s website: https://pathbio.med.upenn.edu/cvpf/site/